Skip to main navigation Skip to search Skip to main content

Clinical and pharmacoeconomic evaluation of switch to olanzapine in veterans with schizophrenia or schizoaffective disorder.

  • Lori L. Davis
  • , Marshall E. Cates
  • , Joette S. Lowe
  • , L. Charles Ward
  • , Jeffrey D. Johnson
  • , Raela B. Williford
  • , Sandra M. Ambrose
  • , Brandi L. Thomas
  • , Terrell Michael Kashner

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)85-98
Number of pages14
JournalPsychopharmacology Bulletin
Volume41
Issue number1
DOIs
StatePublished - 2008
Externally publishedYes

ASJC Scopus Subject Areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Keywords

  • Economics, Pharmaceutical
  • Olanzapine
  • Veterans
  • Humans
  • Middle Aged
  • Benzodiazepines/economics
  • Male
  • Health Care Costs
  • Cost-Benefit Analysis
  • Psychotic Disorders/drug therapy
  • Quality of Life
  • Adult
  • Female
  • Aged
  • Retrospective Studies
  • Schizophrenia/drug therapy
  • Antipsychotic Agents/economics

Cite this